000 01184 a2200313 4500
005 20250515041744.0
264 0 _c20061207
008 200612s 0 0 eng d
022 _a0149-2918
024 7 _a10.1016/j.clinthera.2006.08.007
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aNguyen, Nancy Thai
245 0 0 _aThe decision-making process of US Food and Drug Administration advisory committees on switches from prescription to over-the-counter status: a comparative case study.
_h[electronic resource]
260 _bClinical therapeutics
_cAug 2006
300 _a1231-1243 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article
650 0 4 _aAdvisory Committees
650 0 4 _aDecision Making
650 0 4 _aDrug Approval
650 0 4 _aDrug Prescriptions
650 0 4 _aHumans
650 0 4 _aNonprescription Drugs
650 0 4 _aUnited States
650 0 4 _aUnited States Food and Drug Administration
700 1 _aCook, Daniel M
700 1 _aBero, Lisa A
773 0 _tClinical therapeutics
_gvol. 28
_gno. 8
_gp. 1231-1243
856 4 0 _uhttps://doi.org/10.1016/j.clinthera.2006.08.007
_zAvailable from publisher's website
999 _c16561317
_d16561317